FDA approves IND application for peanut allergy drug candidate September 16, 2021 Auto Bot Markets & Regulations 0 The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.